| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |